Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Cutia Therapeutics (CUT HK)
Watchlist
7
Analysis
Health Care
•
China
Established in 2019 with headquarters in Shanghai, Cutia is an R&D based company mainly focusing on dermatology and aesthetics.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Horizon Robotics
•
23 Feb 2025 01:55
HSCI Index Rebalance: 29 Adds, 41 Deletes & Changes to Southbound Stock Connect
There are 29 adds/ 41 deletes for the HSCI in March. We expect 27 inclusions and 28 deletions for Southbound Stock Connect. There are big holdings...
Brian Freitas
Follow
561 Views
Share
bearish
•
Shanghai Henlius Biotech
•
14 Jan 2025 15:22
Henlius (2696 HK): Hurtling Towards a Likely Deal Break
LVC’s trading behaviour suggests that it is likely to block the vote. Fosun Pharma has two potential options to secure LVC’s backing. Both have...
Arun George
Follow
540 Views
Share
bullish
•
Shanghai Henlius Biotech
•
13 Jan 2025 07:58
Henlius (2696 HK): Test of Nerves Awaiting LVC’s Next Move
There are valid arguments for LVC to block the vote and support the offer. LVC’s trading behaviour over the coming days will point to its voting...
Arun George
Follow
641 Views
Share
bullish
•
Shanghai Henlius Biotech
•
07 Jan 2025 15:02
Henlius (2696 HK): Anxiety Creeping Back Ahead of the 22 January Vote
Several readers have enquired about my thoughts on the widening spread. Our conversations have raised several potential concerns that could explain...
Arun George
Follow
606 Views
Share
bullish
•
Cutia Therapeutics
•
24 Jul 2023 22:53
•
Broker
Cutia Therapeutics (2487 HK) – Well-positioned to capture broader dermatology market potential
Cutia is one of the few players in the broader dermatology treatment and care market in China equipped with fully integrated capabilities.
CMB International
Follow
204 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.49.0
x